AI-enhanced Heart MRI for Evaluating Blood Flow
ConditionIschemic Heart Diseases
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorIRCCS San Raffaele
About this trial
This study will compare the standard MRI protocol with an advanced MRI protocol for the assessment of ischemic heart disease. The goal is to evaluate whether the advanced protocol provides comparable or improved diagnostic performance relative to the standard approach.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Consecutive adults (≥18 y.o.) admitted to the UO for cardiac MRI with or without stress
Disqualifiers
Refused to consent
Claustrophobia
Metal prosthesis potentially affecting image quality
Trial population
Consecutive adults attending the U.O Advanced Imaging for Personalized Medicine to be submitted to stress cardiac MRI study
Trial design
Design model
Other
Time perspective
Prospective
Treatments tested in this trial
Accelerated advanced MRI sequences protocol
Diagnostic testThe accelerated advanced MRI sequences will be compared with standard MRI sequences to evaluate their relative efficiency.
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Noninferiority of accelerated advanced MRI sequences compared to standard MRI sequences, assessed using a paired Wilcoxon signed-rank test at a one-sided significance level of 0.025.
Time frame
3 yearsLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: